Skip to main content

Oxford Cannabinoid Technologies "proceeding forward as planned" after review meeting

Oxford Cannabinoid Technologies Holdings PLC (LSE:OCTP, OTCQB:OCTHF) CEO Clarissa Sowemimo-Coker speaks to Proactive after announcing that a Research Ethics Committee (REC) review meeting for its lead programme OCT461201 has now taken place. Sowemimo-Coker says the company is "proceeding forward as planned" and has "hit the ground running" in 2023.

Contact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

Recent Quotes

View More
Symbol Price Change (%)
AMZN  209.85
+4.58 (2.23%)
AAPL  271.92
+5.74 (2.16%)
AMD  214.94
+18.34 (9.33%)
BAC  50.65
-0.42 (-0.83%)
GOOG  310.62
-1.07 (-0.34%)
META  640.28
+3.03 (0.47%)
MSFT  387.84
+3.37 (0.88%)
NVDA  192.60
+1.05 (0.55%)
ORCL  146.36
+5.05 (3.57%)
TSLA  407.90
+8.07 (2.02%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.